Earnings
NEO
44.89
+1.10%
0.49
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
228.71M
67.55M
--
106.84M
--
--
0.00
--
29.53M
--
11.55M
4.55M
448.73M
131.66M
--
29.55M
--
211.08M
120.65M
--
46.65M
539.60M
988.33M
--
24.96M
0.00
--
--
--
--
--
41.35M
--
--
--
4.03M
73.18M
169.09M
--
--
5.42M
46.35M
220.85M
294.04M
112.00K
701.36M
-7.18M
--
--
--
694.29M
694.29M
988.33M
FY 2019-12-31
173.02M
--
--
94.24M
--
--
0.00
--
14.40M
--
6.33M
2.75M
290.74M
90.68M
--
--
--
198.60M
126.64M
--
2.85M
418.77M
709.51M
--
19.57M
0.00
--
--
--
--
--
32.29M
--
--
--
1.61M
63.90M
95.03M
--
--
15.57M
27.60M
138.19M
202.10M
105.00K
520.28M
-11.36M
--
--
--
507.41M
507.41M
709.51M
FY 2018-12-31
9.81M
--
--
76.92M
--
--
0.00
--
8.65M
--
7.73M
561.00K
103.67M
60.89M
--
--
--
197.89M
140.03M
--
2.54M
401.35M
505.01M
--
17.78M
0.00
--
--
--
--
--
28.05M
--
--
--
927.00K
60.92M
98.13M
--
--
22.46M
3.06M
123.65M
184.57M
94.00K
372.19M
-51.26M
--
--
--
320.44M
320.44M
505.01M
FY 2017-12-31
12.82M
--
--
60.43M
--
--
0.00
--
7.47M
--
4.15M
1.00M
85.88M
36.50M
--
--
--
147.02M
74.17M
--
891.00K
258.58M
344.45M
--
10.45M
0.00
--
--
--
--
--
15.63M
--
--
--
1.41M
36.47M
96.44M
--
--
6.69M
283.00K
103.41M
139.88M
80.00K
230.03M
-58.42M
--
--
--
204.58M
204.58M
344.45M
FY 2016-12-31
12.53M
--
--
55.51M
--
--
0.00
--
6.25M
--
--
4.54M
78.83M
34.04M
--
--
--
147.02M
77.06M
--
174.00K
258.29M
337.12M
--
16.78M
0.00
--
--
--
--
--
12.60M
--
--
--
--
38.11M
97.44M
--
--
14.97M
--
112.41M
150.52M
79.00K
216.10M
-52.46M
--
--
--
186.60M
186.60M
337.12M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NEO latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Neogenomics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.